GlassScriptPhysician profile
Alexandra Leonard
NPI 1538715990
$3,484.58
in general payments reported to CMS, 2019-2025
11 companies · $15.66 in 2025
The $15.66 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $750 · 2023: $2,285 · 2024: $273 · 2025: $15.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,519 · Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,519.41 |
| Food and Beverage | $1,054.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,726.76 | 2023-2025 | |
| Janssen Biotech, INC. | $357.64 | 2021-2022 | |
| Ucb, INC. | $343.19 | 2022-2023 | Cimzia |
| Janssen Scientific Affairs, LLC | $265.70 | 2022-2023 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $169.99 | 2022-2023 | Sotyktu |
| Galderma Laboratories, L.P. | $144.42 | 2023 | |
| Pfizer INC. | $128.60 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.95 | 2023 | |
| Novartis Pharmaceuticals Corporation | $108.54 | 2022 | |
| Genzyme Corporation | $95.34 | 2024 | |
| Pierre Fabre Pharmaceuticals, INC. | $19.45 | 2023 | Hemangeol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.